Preview

Rational Pharmacotherapy in Cardiology

Advanced search

LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK (LIS-2). DESIGN AND MEDICAL TREATMENT ESTIMATION

https://doi.org/10.20996/1819-6446-2013-9-2-114-122

Full Text:

Abstract

Aim. Estimation of social, demographic and anamnestic characteristics of patients survived cerebral stroke as well as the medical treatment received by the patients before the reference stroke in the hospital and at discharge within the framework of the stroke register LIS-2 (study of mortality among patients survived stroke in Lyubertsy district).

Material and methods. All the patients (637 persons) admitted to the Lyubertsy regional hospital №2 due to stroke from 01.01.2009 to 31.12.2010 were enrolled into the study.

Results. 36% were men and 64% were women with mean age of 70.99Ѓ}9.6 years old. 554 (87.0%) patients had history of arterial hypertension and 155 (24.3%) – of atrial fibrillation.147 (23.1%) patients had previous stroke. In-hospital mortality made up 21.8% (mean age of 139 deceased patients was 72.7Ѓ}9.6 years old). 374 (75%) patients were prescribed ACE inhibitors, 421 (85%) - antiplatelet agents, 4 (1%) – warfarin. Statins intake was recommended to 3 (1%) patients.

Conclusion. We revealed low frequency of prescription of drugs with proven positive prognostic value in patients after stroke.

About the Authors

S. A. Boytsov
State Research Centre for Preventive Medicine, Moscow
Russian Federation

Sergey A. Boytsov - PhD, MD, Professor, Director of the State Research Centre for Preventive Medicine (SRCPM), Head of Department of Clinical Cardiology and Molecular Genetics of the same Center



S. Yu. Martsevich
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Sergey Yu. Martsevich - PhD, MD, Professor, Head of Department of Preventive Pharmacotherapy

 



M. L. Ginzburg
Lyubertsy Regional Hospital №2, Moscow Region, Lyubertsy
Russian Federation

Moisei L. Ginzburg - PhD, MD, Head of Cardiology Department, Lyubertsy 



N. P. Kutishenko
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Natalia P. Kutishenko - PhD, MD, Head of Laboratory of Pharmaco-Epidemiological Research, Department of Preventive Pharmacotherapy


L. Yu. Drozdova
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Lyubov Yu. Drozdova — PhD, MD, Senior Researcher, Department of Preventive Pharmacotherapy


A. V. Akimova
State Research Centre for Preventive Medicine, Moscow
Russian Federation

Anna V. Akimova – MD, Junior Researcher of the same Department



A. Yu. Suvorov
State Research Centre for Preventive Medicine, Moscow
Russian Federation

Alexander Yu. Suvorov - Junior Researcher of the same Department



M. M. Loukianov
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Mikhail M. Lukyanov - PhD, MD, Leading Researcher of Department of Clinical Cardiology and Molecular Genetics


N. A. Dmitrieva
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Nadezhda A. Dmitrieva - PhD, MD, Researcher, Department of Preventive Pharmacotherapy


O. V. Lerman
State Research Centre for Preventive Medicine, Moscow
Russian Federation

Olga V. Lerman - PhD, MD, Senior Researcher of the same Department



N. Yu. Zhuravskaya
State Research Centre for Preventive Medicine, Moscow
Russian Federation

Natalia Yu. Zhuravskaya – MD, Ph.D. candidate of the same Department



E. V. Daniels
Lyubertsy Regional Hospital №2, Moscow Region, Lyubertsy
Russian Federation
Elena V. Daniels - MD, Doctor of Cardiology Department,


A. V. Fokina
Lyubertsy Regional Hospital №2, Moscow Region, Lyubertsy
Russian Federation

Anna V. Fokina – MD, Doctor of the same Department



V. N. Yudaev
Public Health Department of Lyubertsy
Russian Federation

Victor N. Yudaev - PhD, MD, Head of Public Health Department of Lyubertsy District



V. P. Smirnov
Lyubertsy Regional Hospital №2, Moscow Region, Lyubertsy
Russian Federation

Vladimir P. Smirnov — PhD, MD, Head of Lyubertsy Regional Hospital №2



A. M. Kalinina
State Research Centre for Preventive Medicine, Moscow
Russian Federation
Anna M. Kalinina – PhD, MD, Professor, Head of Department of Primary Prevention of Chronic Non-Communicable Diseases in the Healthcare System


S. V. Kotov
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
Russian Federation

Sergey V. Kotov - PhD, MD, Professor, Head of Chair of Neurology of Postgraduate Education Faculty, Moscow Regional Research Clinical Institute named after M.F. Vladimirsky, Head of Neurology Unit of the same Institute, Chief-Neurologist of the Moscow Region



L. V. Stahovskaya
Pirogov Russian National Research Medical University, Moscow
Russian Federation
Ludmila V. Stakhovskaya - PhD, MD, Professor of Chair of Basic and Clinical Neurology and Neurosurgery i>


References

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-- 2013 update: a report from the American Heart Association. Circulation 2013;127(1):e6–e245.

2. Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16 Suppl 1:14–9.

3. Mohan KM, Wolfe CD, Rudd AG, et al. Risk and cumulative risk of stroke recurrence: a systematic reviewand meta-analysis. Stroke 2011;42(5):1489–94.

4. Baker WL, Marrs JC, Davis LE, et al. Key Articles and Guidelines in the Acute Management and Secondary Prevention of Ischemic Stroke. Pharmacotherapy 2013 Feb 11 [Epub ahead of print].

5. Moustafa RR, Baron JC. Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br J Pharmacol 2008;153 Suppl 1:S44–54.

6. Frizzell JP. Acute stroke: pathophysiology, diagnosis, and treatment. AACN Clin Issues 2005;16(4): 421–40.

7. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42(2):517–84.

8. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/ american stroke association. Stroke 2011;42(1):227–76.

9. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378(9798):1231–43.

10. Spirin N.N., Korneeva N.N. Kostroma in-hospital stroke register data. Fundamental research 2012; 4(1): 123-8. Russian (Спирин Н.Н., Корнеева Н.Н. Данные госпитального регистра инсульта в Костроме. Фундаментальные исследования 2012; 4(1):123–8).

11. Khutieva L.S., Efremov V.V. Clinical-epidemiological characteristics and stroke risk factors in the republic of Ingushetia. New technologies. 2012;1: 234-9. Russian (Хутиева Л.С., Ефремов В.В. Клинико-эпидемиологическая характеристика и факторы риска мозговых инсультов в республике Ингушетия. Новые технологии 2012;1: 234–9).

12. Lebedev I.A., Anishchenko L.I., Akinina S.A., Ivanova N.E., Sokolova A.A. Clinical-epidemiological particularities of cerebral stroke in the Khanty-Mansijsk Autonomous District (in accordance to a population register). The Russian Military Medical Academy reporter 2011;3:103-7. Russian (Лебедев И.А., Анищенко Л.И., Акинина С.А., Иванова Н.Е., Соколова А.А. Клинико-эпидемиологические особенности мозгового инсульта в Ханты-Мансийском автономном округе (по данным популяционного регистра). Вестник Российской военно-медицинской академии 2011;3:103–7).

13. Kotova E.Yu., Mashin V.V. Epidemiology and the main risk factors of stroke in Ulyanovsk (in accordance to a stroke register). Ulyanovsk medical –biological journal 2011; 2:100-7. Russian (Котова Е.Ю., Машин В.В. Эпидемиология и основные факторы риска развития инсульта в г. Ульяновске (по данным регистра инсульта). Ульяновский медико-биологический журнал 2011; 2:100–7).

14. Bidenko M.A., Shprah V.V., Martynenko E.A. Structure, outcomes and risk factors of cerebral stroke in accordance to in-hospital register data in Irkutsk. Suberian medical journal 2008;79( 4):61-4. Russian (Биденко М.А., Шпрах В.В., Мартыненко Е.А. Структура, исходы и факторы риска мозговых инсультов по данным госпитального регистра в г.Иркутске. Сибирский медицинский журнал 2008;79( 4):61–4).

15. Martsevich S.Yu., Voronina V.P., Drozdova L.Yu. Doctor’s health and education: two components of success. RPC 2010;6(1):73-6. Russian (Марцевич С.Ю., Воронина В.П., Дроздова Л.Ю. Здоровье и образование врача: две составляющие успеха. РФК 2010;6(1):73–6).

16. Khelia T.G., Martsevich S.Yu., Selivanova G.B. and others. Assessment of awareness about contemporary principles of rational medical treatment for cardiovascular diseases in accordance to inquiry of primary care doctors in Moscow. Cardiovascular therapy and prevention 2012;11(5):61-6. Russian (Хелия Т.Г., Марцевич С.Ю., Селиванова Г.Б., и др. Изучение знания современных принципов рациональной фармакотерапии сердечно-сосудистых заболеваний по данным опроса врачей первичного звена здравоохранения города Москвы. Кардиоваскулярная терапия и профилактика 2012;11(5):61–6).

17. Julian DG. Translation of clinical trials into clinical practice. J Intern Med. 2004 Mar;255(3):309–16.

18. Fletcher RH, Fletcher SW. Clinical epidemiology : the essentials. 5th ed. Philadelphia, Pa. ; London: Lippincott Williams & Wilkins; 2013.

19. Martsevich S.Yu., Ginzburg M.L., Kutishenko N.P. and others. The LIS research (study of mortality among patients survived acute myocardial infarction in Lyubertsy district): a portrait of a diseased. Cardiovascular therapy and prevention 2011;10(6):89-93. Russian (Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда): портрет заболевшего. Кардиоваскулярная терапия и профилактика 2011;10(6):89–93).

20. Martsevich S.Yu., Ginzburg M.L., Kutishenko N.P. and others. The LIS research (study of mortality among patients survived acute myocardial infarction in Lyubertsy district). Estimation of medical treatment. Part 1. How patients are treated before myocardial infarction and how this impacts on in-hospital mortality. RPC 2012;8(5):681-684. Russian (Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда). Оценка лекарственной терапии. Часть 1. Как лечатся больные перед инфарктом миокарда, и как это влияет на смертность в стационаре. РФК 2012;8(5):681–684).

21. Martsevich S.Yu., Ginzburg M.L., Kutishenko N.P. and others. The LIS research (study of mortality among patients survived acute myocardial infarction in Lyubertsy district). Estimation of medical treatment. Part 2. Influence of previous medical treatment on patients long-term life prognosis. RPC 2012;8(6):738-745. Russian (Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда). Оценка лекарственной терапии. Часть 2. Влияние предшествующей лекарственной терапии на отдаленный прогноз жизни больных). РФК 2012;8(6):738–745).


For citation:


Boytsov S.A., Martsevich S.Y., Ginzburg M.L., Kutishenko N.P., Drozdova L.Y., Akimova A.V., Suvorov A.Y., Loukianov M.M., Dmitrieva N.A., Lerman O.V., Zhuravskaya N.Y., Daniels E.V., Fokina A.V., Yudaev V.N., Smirnov V.P., Kalinina A.M., Kotov S.V., Stahovskaya L.V. LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK (LIS-2). DESIGN AND MEDICAL TREATMENT ESTIMATION. Rational Pharmacotherapy in Cardiology. 2013;9(2):114-122. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-2-114-122

Views: 794


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)